Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1951 AL 1965

Principles underlying the Bilingual Aphasia Test (BAT) and its uses

Paradis M.

Clin Linguist Phon. 2011 Jun;25(6-7):427-43. doi: 10.3109/02699206.2011.560326.

Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases

Grammas P, Martinez J, Miller B.

Expert Rev Mol Med. 2011 Jun 10;13:e19. doi: 10.1017/S1462399411001918.

Role of LRRK2 kinase dysfunction in Parkinson disease

Kumar A, Cookson MR.

Expert Rev Mol Med. 2011 Jun 13;13:e20. doi: 10.1017/S146239941100192X.

Falls in Parkinson's disease: evidence for altered stepping strategies on compliant surfaces

Cole MH, Silburn PA, Wood JM, Kerr GK.

Parkinsonism Relat Disord. 2011 Sep;17(8):610-6. doi: 10.1016/j.parkreldis.2011.05.019. Epub 2011 Jun 14.

Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial

Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, Bienfait KL, Friedman J.

Am J Psychiatry. 2011 Oct;168(10):1066-74. doi: 10.1176/appi.ajp.2011.10111669. Epub 2011 Jun 15.

DBS, Parkinson's disease, and suicide

Saleh C.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):E4. doi: 10.1176/jnp.23.2.jnpe4.

Temporary interruption of deep brain stimulation for Parkinson's disease during outpatient electroconvulsive therapy for major depression: a novel treatment strategy

Ducharme S, Flaherty AW, Seiner SJ, Dougherty DD, Morales OG.

J Neuropsychiatry Clin Neurosci. 2011 Spring;23(2):194-7. doi: 10.1176/jnp.23.2.jnp194.

[Yeast as a model for studying neurodegeneration]

Wawrzycka D.

Postepy Hig Med Dosw (Online). 2011 Jun 2;65:328-37. doi: 10.5604/17322693.945767.

Translational research on prolyl oligopeptidase inhibitors: the long road ahead

Lambeir AM.

Expert Opin Ther Pat. 2011 Jul;21(7):977-81. doi: 10.1517/13543776.2011.587803.

Neuroproteomics and Parkinson's disease: don't forget human samples

Licker V, Burkhard PR.

Expert Rev Proteomics. 2011 Jun;8(3):291-4. doi: 10.1586/epr.11.29.

The SODyssey: superoxide dismutases from biochemistry, through proteomics, to oxidative stress, aging and nutraceuticals

D'Alessandro A, Zolla L.

Expert Rev Proteomics. 2011 Jun;8(3):405-21. doi: 10.1586/epr.11.13.

LRRK2 Parkinson's disease: from animal models to cellular mechanisms

Lin CH, Tsai PI, Wu RM, Chien CT.

Rev Neurosci. 2011;22(4):411-8. doi: 10.1515/RNS.2011.036. Epub 2011 Jun 17.

Progress in defining the premotor phase of Parkinson's disease

Tolosa E, Pont-Sunyer C.

J Neurol Sci. 2011 Nov 15;310(1-2):4-8. doi: 10.1016/j.jns.2011.05.027. Epub 2011 Jun 15.

Therapies for dopaminergic-induced dyskinesias in Parkinson disease

Gottwald MD, Aminoff MJ.

Ann Neurol. 2011 Jun;69(6):919-27. doi: 10.1002/ana.22423.

The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal

Shearer J, Green C, Counsell CE, Zajicek JP.

Appl Health Econ Health Policy. 2011 Jul 1;9(4):243-58. doi: 10.2165/11590160-000000000-00000.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias